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Taylor Ray Mayberry. Neuromodulation of Spinal Pathways Involved in Chronic Pain: 
Implications for Motor Rehabilitation. (Under the direction of Nathan C. Rowland). 
 
Lower thoracic dorsal column epidural stimulation is a common intervention in 
the treatment of chronic low back and leg pain (CLBLP). This has traditionally been 
carried out using low frequency (1-100 Hz) tonic stimulation (LFTS). LFTS has also been 
studied in the context of spinal cord injury (SCI) and has been found to selectively 
activate motor nerve roots in persons with paraplegia, some of whom have regained 
partial ambulation using this technique. A known adverse effect of LFTS is attenuation of 
proprioception. Recent advancements in spinal cord stimulation (SCS) technology using 
high frequency (1-10 kHz) burst stimulation (HFBS) have demonstrated pain mitigation 
comparable to LFTS, however effects on motor neuron and proprioceptive activity using 
this new modality are poorly understood. For this thesis work, one individual with CLBLP 
underwent electromyography (EMG) recording from lower extremity muscles during 
intraoperative SCS placement (Spectra WaveWriter™, Boston Scientific, Marlborough, 
MA) to investigate pain mitigation and motor neuron activation in response to HFBS. 
Proprioception was also tested extraoperatively using a threshold to detect passive 
motion (TTDPM) protocol in which LFTS and HFBS were compared with respect to 
perception of movement around the knee joint. Finally, the subject performed a gait task 
on an instrumented treadmill while recording EMG from lower extremity muscles and 
switching between SCS modalities. Extraoperative SCS testing at rest revealed that 
HFBS correlated with a significant increase in EMG amplitude (p < 0.01) and decreased 
interpeak interval (IPI) (p < 0.01) of evoked potentials compared to LFTS. TTDPM 
showed similarity between HFBS and no stimulation, while LFTS resulted in reduced 
capacity to perceive change in passive knee flexion/extension (p < 0.01). EMG analysis 
showed thoracic SCS with HFBS, but not LFTS, did not alter normal gait patterns, 
including foot swing and step height (p < 0.01). Our results indicate that thoracic HFBS 
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may influence motor neuron activity without attenuating important proprioception 
signaling compared to LFTS and may represent a potential therapeutic modality for 





Chronic low back and leg pain (CLBLP) is a leading cause of disability worldwide, 
and an estimated 34,000 spinal cord stimulation (SCS) surgeries are performed annually 
to alleviate debilitating CLBLP.1 Approved by the FDA in 1989 for the treatment of 
chronic neuropathic pain, SCS modulates excitability of large, low-threshold A fibers 
(non-nociceptive) along the dorsal column which synapse onto interneurons that inhibit 
ascending pain transmission toward the brain. Although traditional mechanistic 
explanations of SCS for treatment of CLBLP, such as the gate control theory, are widely 
accepted, stimulator technology that has emerged in the last decade is far less 
understood. For example, pain reduction via SCS has traditionally utilized low-frequency 
tonic stimulation (LFTS), which is generally applied at frequencies less than 100 Hz and 
produces paresthesias (i.e., a tingling sensation) at sensory threshold amplitudes 
thought to be necessary for targeting areas of pain.2 However, recent evidence suggests 
that the induction of paresthesias via LFTS may compromise proprioceptive information 
flowing from the periphery to the spinal cord, thus potentially adversely modulating spinal 
projections involved in motor behaviors such as standing and walking.3,4  In contrast, 
recent studies suggest higher frequencies (e.g., up to 10,000 Hz) and complex 
waveforms of stimulation such as high-frequency burst stimulation (HFBS) can attenuate 
pain perception without producing paresthesias. Nevertheless, the potential effect of 
HFBS on proprioceptive signaling and ability to influence ventral motoneuron (MN) pools 
has only recently begun to be investigated.  
Motoneurons residing in the ventral aspect of the spinal cord rely on descending 
drive from the brain and afferent input from the periphery to shape voluntary movement.5 
In 2009, Harkema et al investigated the effects of SCS on MN activation utilizing LFTS 
ranging from 5-60 Hz (frequency) in subjects with complete spinal cord injury (SCI). 
LFTS of the lumbosacral spinal cord segments (T11 - L2) was found to elicit activation in 
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lower extremity musculature previously thought to be quiescent in these spinal cord 
injured individuals. In one subject, surface electromyography (EMG) showed that SCS 
facilitated activation of extensors during assisted standing, rhythmic activity during 
assisted walking and appropriate modulation of on/off states during assisted weight 
shifting tasks.6 Notwithstanding, Formento et al found that LFTS interrupts proprioceptive 
sensory information from the lower extremities that helps shape motor activity. The 
amount of compromised afferent information during traditional spinal cord stimulation via 
LFTS was postulated to be dependent on the quantity of dorsal column primary afferents 
recruited and proportional to increases in current and pulse width.3  In the Formento 
study, 3 subjects were implanted with a 16-contact epidural paddle array and 
implantable pulse generator (IPG) (Activa RC, Medtronic, Fridley, Minnesota) along the 
lumbosacral spinal cord (T11 – L2). Proprioception was tested using an isokinetic 
dynamometer to passively flex and extend the knee while subjects were seated. Knee 
flexion/extension was applied until subjects reported perceiving movement. Compared to 
no stimulation, LFTS parameters (15-100 Hz, 210–450 s, 4.5–9.0 mA) were found to 
cause a significant loss (p < .05) of perceived position sense during passive movement 
when stimulation amplitudes were high enough to innervate their homonymous motor 
neuron pool to activation threshold (as measured by EMG). Interestingly, in the same 
study, although the epidural stimulator used during proprioceptive testing was only 
capable of stimulating at 125 Hz, by interleaving 4 stimulation programs with a 2 ms 
delay the group was able to create a 4-pulse 500 Hz bursting pattern. HFBS at 500Hz 
was found to elicit motor neuron activation with a 39.8% reduction in current amplitude 
when compared to 20 Hz LFTS. These two studies together demonstrate that while SCS 
is designed to directly modulate dorsal column pathways, a better understanding of 
exactly how fibers and neuronal pools are stimulated might possibly allow activation of 
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both ventral and dorsal columns in a way that benefits motor and sensory information 
processing. 
Since the epidural space is exposed during surgical placement of the SCS 
device, information about a subject’s motor and sensory spinal pathways can be easily 
obtained during the regular course of the procedure and compared to proprioceptive and 
motor responses once the subject is awake and moving with the device turned on. Our 
lab specializes in electrophysiological recordings in subjects undergoing spinal cord 
stimulator (SCS) implantation for CLBLP, while the Locomotion Laboratory at the 
Medical University of South Carolina (MUSC) specializes in quantifying proprioception 
and movement in human subjects. In order to examine potential differences in 
modulating sensorimotor pathways between traditional LFTS and newly developed 
HFBS parameters, this project investigated 3 specific aims:  
Aim 1. Investigate the effect of LFTS on sensory thresholds intraoperatively. 
Question: Does LFTS modulate the activity of ascending sensorimotor pathways? 
In this aim, we measured somatosensory evoked potential thresholds in a subject 
undergoing SCS implantation during stimulation of epidural paddle contacts. We 
hypothesized that LFTS would reduce somatosensory evoked potential thresholds.  
Aim 2. Determine the effect of HFBS on proprioceptive afferent signaling from the 
lower extremities. Question: Does HFBS, when compared to traditional LFTS, allow 
for increased spatial limb awareness during passive motion? In this aim, the 
postoperative subject from SA1 underwent isokinetic passive proprioceptive testing 
before and during spinal cord stimulation with HFBS and LFTS parameters targeting 
sensation surrounding the knee. We hypothesized that the subject would have increased 
awareness of the lower limb in space through passive movement during optimal HFBS 
compared to optimal LFTS parameters. 
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Aim 3. Determine the effect of HFBS on lower extremity muscle activity during 
gait. Question: Does HFBS, when compared to LFTS, differentially affect muscle 
synergy patterns during gait? In this aim, the subject from SA1 and SA2 performed 
treadmill walking before and during SCS stimulation. The subject was monitored with 
surface EMG and 3-D kinematic tracking software to quantify changes in gait pattern. 
We hypothesized that the subject would have increased EMG module complexity during 
gait with HFBS compared to LFTS or no stimulation. 
If we are able to identify HFBS parameters that preserve proprioceptive signaling 
while attenuating pain, in future studies we may be able to apply these parameters for 
simultaneous treatment of neuropathic pain and movement rehabilitation in patients with 
chronic motor dysfunction, such as those with spinal cord injury and stroke.  
 
1.1  PAIN SIGNALING 
Pain signaling involves nociceptor-triggered action potentials along Aδ and C 
primary afferent 
fibers in response 
to physical and 
chemical insult 
(Fig.1). As a result 
of activation of 
nociceptive fibers, 
glutamate and 
substance P are 
released within 
lamina I and II of the dorsal horn of the spinal cord (DHSC)(Fig. 2). 9,10 
Figure 1: Image and caption modified from [7]. Illustration of nociceptive signaling to the 
dorsal horn of the spinal cord. 
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Within the DHSC, 2nd 
order fibers carrying pain signals 
cross the midline and ascend as 
part of the anterolateral system 
(i.e., spinothalamic, spinoreticular 
and spinomesencephalic tracts) 
where axons synapse within the 
midbrain and thalamus for pain 
perception processing.11  
1.1.1  CHRONIC PAIN 
Chronic pain is defined by 
the International Association for 
the Study of Pain (IASP) and 
World Health Organization 
(WHO) as pain that persists beyond the normal time of healing and is clinically 
recognized by debilitating pain longer than three months in more than one anatomical 
location (e.g., low back and leg).12  Chronic pain was identified as one of the top causes 
of disability in the world in the 2017 Global Burden of Disease Study compiled by the 
Institute for Health Metrics and Evaluation.13 Chronic pain may be further delineated into 
a subcategory of pain relating specifically to damage of the peripheral or central nervous 
system. The current International Classification of Diseases (ICD-11) defines chronic 
neuropathic pain as pain caused by a lesion or disease of the somatosensory nervous 
system.14 Chronic neuropathic pain is generally thought to be caused by dysregulation of 
nociceptive signaling and can lead to normal mechanical stimuli being perceived as 
painful (allodynia) or painful stimuli being perceived as a much higher intensity of pain 
Figure 2: Image and caption modified from [8]. Illustration of lamina I-
VI of the DHSC, with nociceptive C-fibers terminating in lamina I-II. 
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(hyperalgesia). Plasticity in the neuron, interneuron, microglia and astrocyte complexes 
within the DHSC stemming from repeated exposure to glutamate and substance P 
release is thought to play critical roles in this dysregulation.15 Existing homeostatic 
mechanisms used to regulate pain perception may be altered in persons suffering from 
chronic pain. Inhibitory interneurons within the superficial laminae of the DHSC have 
GABAergic projections to 2nd order neurons responsible for modulating pain 
transmission to higher brain centers. These inhibitory interneurons are thought to be 
regulated by primary nociceptive (Aδ and C) and mechanoreceptor (Aβ) afferent fibers, 
with loss of this tight regulation leading to excessive pain perception. Another potential 
mechanism of chronic pain suggests involvement of the inflammatory cascade. In 
rodents, Substance P injection showed significant decrease in pain response time (p < 
.05) to painful stimulus applied to the hind paw compared to saline injection.16 In 
humans, Hagermark et al showed a localized inflammatory response to intradermal 
injection of substance P.17 Using transgenic mice that allowed for ablation of microglia 
expressing CX3CR1+ (chemokine receptor), Peng and colleagues investigated the role of 
microglia within the DHSC following spinal nerve transection (SNT). Immediately 
following SNT, hind paw withdrawal reflex to noxious thermal stimuli showed no 
significant difference among control and microglia ablated mice. However, three days 
post-SNT, control mice showed significant decrease in withdrawal latency to noxious 
stimuli (p < .001) compared to the knockout group.18 Together, these studies indicate 
that inflammatory response from acute peripheral nerve injury may facilitate cellular 
changes that increase excitability of nociceptive pathways and highlight the complex 





1.1.2  GATE CONTROL THEORY 
Important work published in 1965 by Melzack et al on the relationship between 
mechanosensory afferents and pain 
within the DHSC continues to serve 
as the best accepted model for the 
regulation of pain signaling nearly a 
half-century later. Known as the 
Gate Control Theory (GCT), Melzack 
postulated that Aβ fibers inhibit 2nd 
order pain-signaling neurons 
resulting in reduced transmission of 
these signals to higher order 
centers. (Fig.3).19 According to Melzack’s theory, this reduction involves inhibitory 
interneurons within the DHSC. Clinicians tested Melzack’s theory by directly modulating 
Aβ fiber axons along the dorsal column pathway using electrical current, eventually 
leading to the development of spinal cord stimulation (SCS) as an effective intervention 
for CLBLP.20 
1.2  SPINAL CORD STIMULATION PARAMETERS FOR CHRONIC PAIN 
SCS is currently used to treat chronic neuropathic pain that may arise from spinal 
injury, disease, and/or previous spinal surgery, for example, in cases of post-
laminectomy syndrome, the most common indication for SCS. SCS surgery represents 
70% of all neuromodulation cases in the United States and is expected to grow as the 
intervention shows continued promise to successfully treat neuropathic pain from these 
and many other etiologies.1 The SCS procedure for CLBLP involves lower thoracic 
placement of epidural electrodes via laminectomy that, when activated, excite Aβ fibers, 
producing a paresthetic sensation along the region of pain. Traditional application of 
Figure 3:Image and caption modified from [8].  Model showing a 
simplified mechanism of pain projection inhibition through Aβ fiber 
activation of dorsal horn inhibitory interneurons 
i  : Image and caption modified from [8].  l i   
i lifi  i  f i  j ti  i i iti  t   fi  
ti ti  f l  i i it  i t
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Figure 5: Image and caption modified from [21]. Illustration of SCS parameters for A) tonic stimulation and 
B) additional parameters for HFBS being interburst frequency and intraburst frequency. 
Figure 6: Image modified from 
[22]. Image of Spectra 
Wavewriter IPG manufactured by 
Boston Scientific (Marlborough, 
MA). Blue box highlights the 
connection ports for the 
stimulator paddle. 
 
SCS utilized a pattern of 
electrical impulses known 
as tonic (constant) 
stimulation, which is 
comprised of three main 
parameters that in 
combination determine the 
intensity of the stimulus: 
frequency (Hz), pulse 
width (µs) and amplitude (mA) (Fig.4).  
 Newer stimulator technology has led to the 
development of implantable pulse generators (IPG) (Fig.5), 
such as the SPECTRA WaveWriter (Boston Scientific, 
Marlborough, MA), that delivers electrical current to the 
epidural contacts in a complex waveform at frequencies up to 
10 KHz (Fig.6). Although the majority of patients receiving 
SCS for chronic pain find the paresthetic effect of low-
frequency tonic stimulation (LFTS) more tolerable than pain 
itself, these complex waveforms, known as high frequency 
burst stimulation (HFBS), have been found to attenuate pain with equal or greater 
Figure 4: Image and caption modified from [21]. Illustration of tonic stimulation 
parameters of frequency, pulse width and amplitude. 
i  : I   ti  ifi  f  [ ]. Ill t ti  f t i  ti l ti  
t  f f , l  i t   lit .
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effectiveness without producing paresthesias. In 2015, a large, multi-center, randomized 
control trial (SENZA-RCT) was conducted to assess the efficacy of high frequency tonic 
stimulation (HFTS) at 10 KHz using the Senza IPG (Nevro, Redwood City, CA) in 
patients with chronic pain of the trunk and/or limbs. The trial consisted of 171 subjects 
receiving surgical placement of an SCS paddle and IPG. Ninety subjects received the 10 
KHz-capable IPG and 81 subjects received IPG implants capable of producing traditional 
tonic stimulation of < 1 KHz. Over 12 months, subjects who received the Senza device 
experienced stimulation at a frequency of 10 KHz with a 30 s pulse width and 
stimulation amplitudes ranging from 1.6 – 3.8 mA, while subjects receiving traditional 
SCS underwent stimulation at a frequency of 39.2 – 133.5 Hz, pulse widths of 347 – 591 
s and stimulation amplitudes ranging from 3.6 – 8.5 mA. After 12 months of stimulation 
both groups were assessed for pain relief via Visual Analog Scale (VAS) of 0 / 10, where 
10 is severe debilitating pain and 0 is no pain. Subjects receiving 10 KHz stimulation 
reported a decrease in VAS from 7.4 ± 1.2 to approximately 2.5, a 67% decrease with no 
reports of paresthesia, whereas subjects receiving traditional LFTS reported a decrease 
in VAS from 7.8 ± 1.2 to approximately 4.3, a 44% decrease in pain rating (p < .001) with 
all subjects perceiving paresthesias.23  
Another study investigating efficacy of HFBS for chronic pain was conducted in 
2017 by Deer et al, in which 100 subjects participated in a randomized crossover trial 
(SUNBURST). All subjects that qualified for the study were implanted with the Prodigy 
SCS IPG manufactured by Abbott (Plano, TX). After surgical placement of the SCS 
paddle and IPG, subjects were initially programmed with tonic stimulation settings of 
frequency ranging from 30 – 100 Hz, pulse width of 100 – 500 s and stimulation 
amplitudes tailored per each subject according to elicitation of comfortable paresthesias 
over the region of pain. Subjects were then separated into two treatment groups, where 
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one group of 45 subjects continued use of tonic stimulation and the other 55 subjects 
received HFBS with an intraburst frequency of 500 Hz, interburst frequency of 40 Hz, 
and pulse width of 1 ms delivered in packets of 5 pulses. Each treatment group received 
their assigned treatment for a total of 12 weeks before the groups were switched to the 
opposite stimulation type. Following 24 weeks of study, the average amplitude of LFTS 
was 6.42 ± 4.00 mA while the average amplitude for HFBS was 1.73 ± 1.05 mA (p < 
.05). The primary outcome measure was perceived pain using a 100 mm VAS, where 0 
is no pain and 100 is severe debilitating pain. At the end of 24 weeks, a significant 
difference was found in favor of HFBS with a 5.1 mm difference between HFBS and 
LFTS regarding VAS rating, and 70.8% of subjects expressed a preference for HFBS 
over LFTS (p < .001).24 These two important studies highlight the increased capability of 
advanced waveform SCS to mitigate pain when compared to traditional stimulation 
parameters.  
1.3  PROPRIOCEPTION SIGNALING 
Muscle spindle fibers 
contain specialized receptors 
located within skeletal muscle that 
sense the length and stretch 
velocity of extrafusal muscle fibers. 
Proximally, muscle spindles form 
primary sensory afferents (Ia and II  
fibers) that project through the 
dorsal root ganglion (DRG) to the 
DHSC and then bifurcate, with 
ventral projections influencing 
Figure 7: Image and caption modified from [8]. Circuitry diagram 
of proprioceptive (Ia) signaling leading to A) excitation of 
homonymous muscle, B) inhibition of antagonist muscle, C) 
excitation of synergist muscles and D) projection to higher brain 
centers via dorsal column pathway. 
Figure 7: I age and caption odified fro  [8]. Circuitry diagra  
of proprioceptive (Ia) signaling leading to A) excitation of 
ho ony ous uscle, B) inhibition of antagonist uscle, C) 
excitation of synergist uscles and ) projection to higher brain 
centers via dorsal colu n. 
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−motor neurons (Fig.7) and ascending tracts within the dorsal column and posterior 
spinocerebellar tracts of the spinal cord projecting to nuclei of the medulla and cerebellar 
cortex respectively. Muscle spindle afferents have been shown to influence −motor 
neurons in three ways: 1) monosynaptic excitation, 2) disynaptic excitation and, 3) 
disynaptic inhibition.25,26,27    
Golgi tendon organs have receptors located at the insertion of extrafusal muscle 
fibers with connective tissue of a tendon that sense changes in muscle tension. Primary 
sensory afferents (Ib fibers) also project through the DRG to the DHSC and then 
bifurcate, with ventral projections influencing inhibitory and excitatory interneurons and 
ascending tracts along the dorsal column and anterior spinocerebellar tracts of the spinal 
cord. The disynaptic effects of Ib fibers on −motor neurons have been previously 
studied in humans by Dietz and colleagues using a body weight support crane to reduce 
load during walking on a treadmill while simultaneously recording surface 
electromyography (EMG). In healthy controls, reduction in body weight of 50% was 
shown to cause significant decrease in extensor muscle activation amplitude during late 
stance when compared to subjects walking with full body weight ( p < .05 ).28 This finding 
suggests that muscle tension information conveyed by Ib fibers of the golgi tendon organ 
influences homonymous muscle activation during walking in an excitatory fashion.  
Sensory afferent modulation of MN excitability is also facilitated by pain signaling 
in Aδ fibers, resulting in a withdrawal reflex to noxious stimuli. Withdrawal from 
cutaneous afferent activation was investigated in 1999 by Andersen et al, where 14 
healthy subjects received noxious electrical stimulation on the sole of the foot in 16 
different locations while sitting upright. Stimulation was delivered at 1.5x subject pain 
response threshold according to the visual analog scale (VAS), guaranteeing Aδ fiber 
recruitment. Surface EMG recording of the gastrocnemius medialis (GM) and tibialis 
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anterior (TA) muscles along with kinematic changes in ankle position using a goniometer 
were collected during stimulation. Stimulation of the distal medial sole elicited robust TA 
activation along with a 6 mean dorsiflexion response, however stimulating the heel 
region of the sole resulted in GM activation and a 2 mean plantarflexion movement. A 
significant difference was found between muscle activation (p < .001) and kinematic 
response (p < .001) to noxious stimuli delivered to different regions along the sole of the 
foot.29 The observations of Andersen and colleagues demonstrate that cutaneous 
afferent fibers influence MN excitability with modular organization, indicating diverse 
projections to both excitatory and inhibitory interneurons that may influence motor 
behavior in someone with chronic pain. 
Spaich and colleagues investigated MN response to noxious stimuli during gait. 
Electrical stimulation, above individual pain threshold, was delivered on the sole of the 
foot for 15 healthy individuals during 4 different phases of the gait cycle being 1) heel 
contact, 2) mid-stance, 3) early swing and 4) late swing. Knee angle measurements 
using a goniometer were continuously recorded during 30 seconds of walking at 3 km/h. 
The magnitude of knee flexion was found to be significantly smaller from stimuli 
delivered during the heel contact and mid-stance phases compared to early swing and 
late swing (p < .05).30 The lack of knee flexion observed during load bearing portions of 
the gait cycle suggests that withdrawal reflex responses to pain may be modulated, at 
least in part, by proprioceptive signaling during a functional task. Thus, primary afferent 
sensory signaling from muscle spindle fibers, golgi tendon organs and Aδ fibers 
influence −MNs and interneurons of the VHSC during functional motor tasks, tightly 
regulating muscle firing to maintain appropriately timed contractions of agonist and 
antagonist muscles around a joint. 
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1.4  MUSCLE ACTIVATION PATTERNS DURING GAIT 
Persons with neurologic insult due to stroke or incomplete SCI can produce 
robust activation of individual flexor or extensor musculature in certain experimental 
conditions. However, in many cases what is 
lost in these disorders is the ability to 
produce fine-tuned, integrated movements 
necessary for dynamic tasks such as 
walking.31 A module-based approach to 
quantify gait patterns was first applied to 
humans in 2004 by Ivanenko32, and 
subsequent work performed in 2010 by 
Clark et al established that gait could be 
represented in four modules. The four 
modules implemented by Clark represent 
four phases of the gait cycle: 1) Early 
Stance, 2) Late Stance, 3) Early Swing, 
and 4) Late Swing.  
EMG-based module groupings during a typical gait cycle are illustrated in Figure 
8, where early stance shown in module 1 is representative primarily of extensor activity 
for weight acceptance with activation seen in the vastus medialis (VM), rectus femoris 
(RF) and gluteus medius (GM). Module 2 represents the late stance phase when 
plantarflexors are active for forward propulsion, facilitated by muscle activity in the 
soleus (SOL) and medial gastrocnemius (MG). Module 3, the early swing phase, shows 
muscle activity primarily in flexors of the hip (rectus femoris or RF) and ankle (tibialis 
anterior or TA). The late swing phase of the gait cycle, module 4, is during deceleration 
of the limb for proper foot placement and is facilitated by increased muscle activity in the 
Figure 8: Image and Caption modified from [29]. Illustration 
of module classifications using groupings of muscle co-
activation amplitude (grey shading) during a walking task in 
20 healthy subjects with group mean (black box). Muscle 
weightings are shown for tibialis anterior (TA), soleus (SO), 
medial gastrocnemius (MG), vastus medialis (VM), rectus 
femoris (RF), lateral hamstring (LH), medial hamstring 
(MH) and gluteus medialis (GM). 
igure 8: I age and aption odified fro  [31]. Illustration 
of odule classifications using groupings of uscle co-
activation a plitude (grey shading) during a alking task in 
20 healthy subjects ith group ean (black box). uscle 
eightings are sho n for tibialis anterior ( ), soleus ( ), 
edial gastrocne ius ( ), vastus edialis ( ), rectus 
fe oris ( ), lateral ha string (L ), edial ha string 
( ) and gluteus edialis ( ). 
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medial and lateral hamstrings (MH) (LH). The ability to coordinate timing-dependent 
muscle co-activations during functional tasks, such as walking, remains dependent, 
however, on appropriate sensory feedback. Recently, Wagner and colleagues 
postulated that SCS delivery in a spatio-temporal, rather than tonic, fashion would 
increase rehabilitation potential in persons with incomplete spinal cord injury due to 
sparing of important proprioceptive signals by minimizing the amount of time when SCS 
is on. The spatio-temporal SCS method involves activation of contacts targeting specific 
posterior nerve roots to recruit musculature facilitating gait in a time-dependent fashion, 
thus allowing natural sensory afferent signaling to reach the spinal cord when SCS is not 
needed and inactive. In their study, SCS implantation over the lumbosacral spinal cord 
(T11 – L2) segments was performed on three male subjects with chronic cervical SCI 
with severe lower limb deficits. Subjects underwent 15 weeks of assisted over-ground 
treadmill walking during spatio-temporal LFTS using a dynamic body weight support 
system. Following 15 weeks of training, subjects performed a walking task during no 
stimulation, LFTS, and spatio-temporal LFTS with full body kinematic tracking allowing 
quantification of step height (cm) and walking speed (m/s). A significant increase in step 
height (p < .001) and walking speed (p < .01) were found in all 3 subjects during spatio-
temporal LFTS supporting their initial hypothesis that primary afferent sensory sparing is 
fundamental to produce proper gait mechanics. A six-minute walking test was used to 
assess ambulation recovery following step training with spatio-temporal SCS. One 
participant increased walking distance from 60 meters to 150 meters while another 
participant increased from 10 meters to 60 meters. The third participant was unable to 
complete unassisted walking, however by using a walker he was able to increase 
walking distance from 0 meters to 300 meters.33 In a companion study investigating SCS 
effects on proprioception, Formento and colleagues created a computational model of 
proprioceptive afferent recruitment in response to SCS. The same model used to 
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indicate the potential benefit of spatio-temporal LFTS also showed a similar benefit using 
HFBS at 600 Hz.3  At the time of these two studies, SCS technology did not allow for 
testing of HFBS parameters at this frequency.  
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2.0  MATERIALS AND METHODS 
2.1  SCS PADDLE PLACEMENT AND ACTIVATION 
This study was approved under IRB protocol # Pro00089881. The subject was 
consented for placement of a spinal cord stimulator paddle for treatment of chronic low 
back and leg pain. The subject was informed that during the procedure EMG and SSEP 
data would be collected and saved at various points during placement. SCS placement 
was performed using a 32-electrode paddle array (CoverEdge™, Boston Scientific, 
Marlborough, MA) (Fig.9) implanted at the T7-9 
vertebral levels. 
 The subject was first placed under 
general anesthesia and positioned prone on the 
operating room table. Subdermal SSEP and 
EMG needle electrodes were placed throughout 
the subject’s body by the neurophysiology team 
as determined by standard of care guidelines. 
2.2  SHORT-LATENCY SOMATOSENSORY EVOKED POTENTIAL (SSEP) 
SSEP testing of the lower extremities is most commonly performed on the 
posterior tibial nerve (PTN). Cortical responses to PTN stimulation are recorded using 
scalp electrodes that are placed according to the 10-20 International System used for 
electroencephalography (EEG) recordings. Electrodes are placed at CPz (centro-
parietal), C3 (left motor cortex), C4 (right motor cortex), and C5 (brainstem). The initial 
cortical waveform seen during PTN stimulation is a positive deflection approximately 37 
Figure 9: Boston Scientific CoverEdge™ 32 
Surgical Lead (left) and fluoroscopic image of 
the stimulator array after implantation along the 
dorsal epidural space (right). 
i r  : t  i tifi  r   
i l  l ft   fl i  i  f 
t  ti l t   ft  i l t ti  l  t  
l i l  i t .
Figure 10: Visualization of baseline SSEP averaging from PTN stimulation recorded between C4-C3 as defined 
by the 10-20 International System. The two teal crosshair markers represent the P37 (left) and N45 (right) 
deflections. 
Figure 10: Visualization of baseline SSEP averaging from PTN stimulation recorded between C4-C3 as defined 
by the 10-20 International System. The two teal crosshair markers represent the P37 (left) and N45 (right) 
deflections. Waveform represents average response to SSEP stimuli (n = 200). 
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milliseconds after stimulation (P37), followed by a negative deflection approximately 45 
milliseconds after stimulation (N45) (Fig.10).34 In this study, PTN stimulation and cortical 
recordings via scalp electrodes were performed using the IOMAX intraoperative 
neuromonitoring platform (model number 100880-937, Cadwell, Kennewick, WA). 
Cortical voltage data were sampled at 250 Hz, bandpass filtered between 30 – 500 Hz 
and responses were averaged every 200 SSEP pulses to calculate averaged 
waveforms. 
2.2.1 SSEP COLLISION TESTING 
SSEPs provide a surrogate measure of the sensory activation threshold of dorsal 
column fibers and can be affected by limb length, body temperature, SCI, spinal 
stenosis/compression, demyelination and neuropathy. The SSEP latencies described 
above can also be modulated by SCS through epidural paddle electrodes using a 
technique known as SSEP Collision Testing. SSEP pulses delivered at a rate of 2.79 Hz 
with an amplitude of 40 mA will show a decrement of the P37 and N45 deflections as the 
parameters of the epidural stimuli are altered. To accomplish this, SCS was delivered at 
a 40 Hz rate with a 300 s pulse width at a starting amplitude of 1.0 mA and increased in 
increments of 1.0 mA until SSEP attenuation occurred, which is confirmed by a 100% 
loss of the P37 waveform.  
2.3  ELECTROMYOGRAPHY (EMG) 
EMG is used to record motor unit 
activation. The motor unit is comprised of a 
single motoneuron (MN) and the muscle fibers 
innervated by that MN (Fig.11).35  The muscle 
fibers innervated by the MN are, like most cells, 
semi permeable structures tightly regulated via Figure 11: Image and caption adapted from [33]. 
Illustration of a single Motor Unit. 
5
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voltage-gated ion channels that at rest allow for flow of potassium (K+) ions out of the 
membrane and restriction of sodium (Na+) ions from entering the cell, resulting in a 
membrane potential of ~ -80mV.  
When a lower MN is activated, the neurotransmitter acetylcholine (ACh) is 
released from motor endplate presynaptic terminals, facilitating conformational changes 
in the voltage-gated channels of muscle fibers leading to Na+ influx and rapid 
depolarization. The wave of depolarization along a group of coactivated muscle fibers 
forms an electric 
dipole and, with the 
application of bipolar 
electrodes placed on 
the skin, underlying 
muscle activity can be 
captured as a 
potential difference in 
voltage between the 
electrodes. Illustrated 
in Figure 12, a wave of depolarization moves along the muscle fibers along several time 
points (T1-T5), where sensing electrodes, outlined in green boxes, connected to an 
amplifier record the potential difference (blue sinusoid) in samples of voltage, resulting in 
both positive and negative deflections in the EMG of equal amplitudes. 
2.3.1 EMG RECORDING DURING SCS ACTIVATION 
In the present study, we performed epidural paddle stimulation while monitoring 
EMG activity. The SCS parameter used were the same LFTS parameters found to 
attenuate the P37 and N45 deflections during the aforementioned SSEP collision testing. 
Figure12: Image and caption modified from [32]. EMG electrode setup used to capture 
electrical signals from underlying muscle tissue. 
i r  12: Image and caption odified fro  [35].  l trode s t p used t  t r  
l tri l i l  fr  rl i  l  ti . 
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Following LFTS, two other parameter settings were tested at the same amplitude 
including: HFBS with 600 Hz intraburst / 40 Hz interburst and HFBS with 1200 Hz 
intraburst / 40 Hz interburst (Fig.13). 
EMG was collected 
intraoperatively using 13 mm 
stainless steel subdermal 
needle electrodes (model # 
RLSP310, Rhythmlink 
International, Columbia, SC) 
at a sampling rate of 3 kHz 
using a 16-channel recording 
device (LR10™, Tucker 
Davis Technologies, Alachua, FL) that served as a signal amplifier and analog-to-digital 
converter. EMG was recorded bilaterally from three lower extremity muscles (Vastus 
Lateralis (VL), Tibialis Anterior (TA), Soleus (SL)) and rectus abdominus muscles to 
allow for visualization of stimulator artifact (Fig.14). During extraoperative EMG 
measurements, 15 x 20 mm conductive vinyl surface EMG self-adhesive electrodes 
(model # PSTCUL15026, Rhythmlink International, Columbia, SC) were placed on the 
skin over the same muscles tested intraoperatively.  
Figure 13: Visualization of EMG tracings during different SCS stimulation 
parameters. Illustration is derived from stimulator artifact captured via 





Following intraoperative testing, the subject was given at least 30 days to recover 
before being asked to return for further extraoperative SCS testing using surface EMG 
as described above.  Given that during intraoperative procedures the subject was placed 
under general anesthesia, performing extraoperative SCS allowed for feedback 
regarding sensory thresholds and quality of pain reduction from LFTS and HFBS 
parameters. Extraoperative EMG recording was performed at perceived sensory 
threshold, 1.5x perceived sensory threshold and 2x perceived sensory threshold for 
each SCS parameter tested. Perceived sensory threshold was established by increasing 
SCS amplitude in increments of 1.0 mA per parameter set until the subject verbally 
reported sensation of the stimulation. Perceived sensory threshold measurements and 
surface EMG were collected while the subject was awake and side-lying. 
 
Figure 14: Visualization of musculature chosen for EMG recording during SCS activation. 
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2.3.2 EMG PROCESSING AND ANALYSIS 
EMG signals at rest (both intra- and extraoperative) were high-pass filtered 
above 10 Hz (MATLAB®, Mathworks, Natick, MA). The frequency of an EMG signal 
typically ranges from 0 – 500 Hz, however true muscle activity may be hard to visualize 
without application of a filter. A 10 Hz high-pass filter is commonly used to attenuate 
noise from background muscle activity. Voluntary movement and movement of the EMG 
leads can also contribute significant noise. Although the subject was under general 
anesthesia during intraoperative SCS testing, noise below 10 Hz was observed in the 
signal presumably from the movement of EMG leads and the use of a compression cuff 
on each leg during surgery to prevent blood clots. Therefore, EMG signals recorded 
during intraoperative and extraoperative SCS were filtered in the same manner. All EMG 
data collected at rest were resampled to 1 KHz. 
Once the subject completed both intraoperative and extraoperative SCS 
sessions with EMG recording, peaks in the EMG time series were examined for evoked 
potentials, which 
typically has a tri-
phasic response 
(Fig.15). Evoked 
potential peaks in 
the time series 
were identified as 
a positive 
deflection in the 
EMG of at least 
30 V from 
Figure 15: Illustration of Top) evoked potentials in EMG signal, Middle) selection of evoked 
potential peaks (red circles) with positive deflections reaching threshold (blue line) and, 
Bottom) IPI histogram of selected potentials. 
Figure 15: Illustration of Top) evoked potentials in EMG signal, Middle) selection of evoked 
potential peaks (red circles) with positive deflections reaching threshold (blue line) and, 
Bottom) IPI histogram of selected potentials. 
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baseline.34 Figure 16 illustrates several examples of evoked potentials in the EMG signal 
(top) identified by our algorithm (middle). The signal in each channel was assumed to 
arise from a single source. This is confirmed using a histogram of the interpeak intervals 
as shown in the bottom panel.  
2.4 PROPRIOCEPTION TESTING 
We investigated the perceived change in knee joint angle and direction of 
movement reported by the subject using a Threshold to Detect Passive Movement 
(TTDPM) task (System 4 Pro™, Biodex Medical Systems, Shirley, NY).3,35  The TTDPM 
protocol, which utilizes an isokinetic/isometric dynamometer, began with the subject 
sitting in the Biodex testing seat and the tested leg strapped to the rotating arm of the 
dynamometer at the lower shank with the non-tested leg resting with approximately 90 
of knee flexion (Fig.16). In order to prevent 
the subject from witnessing initiation, 
direction and approximate distance 
traveled of the shank, the subject wore a 
blindfold and headphones playing a pink 
background noise. Pink noise is defined as 
noise in which the power spectral density 
of the signal is inversely proportional to the 
frequency, thus the amount of energy is 
consistent along all frequencies. Pink noise 
is bandpass filtered between 20-20,000 Hz 
and is designed specifically to mask electrical noise produced by the Biodex 
dynamometer. 
Figure 16: Image and caption modified from [35]. Illustration 
of the TTDPM using a Biodex Dynamometer 
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The TTDPM consisted of at least 10 trials for each stimulation condition, with the 
dynamometer moving at a rate of 1/second in a randomized flexion / extension 
direction. The subject controlled a handheld switch that immediately halted movement of 
the dynamometer arm, which was to be activated once the subject perceived movement 
or if the subject began to feel any pain or discomfort throughout the task. Once the 
dynamometer arm was stopped, the change in knee angle was recorded by the Biodex 
software. The subject in this study reported discomfort during passive right hip flexion, 
therefore TTDPM testing was only performed on the left leg. The SCS paddle was 
activated along the leftmost column of contacts on the epidural paddle, with the bottom 
left contact selected as the anode (+) and the superior 7 contacts equally distributed as 
cathodal (-) contacts. Both LFTS and HFBS over the chosen contacts produced 
paresthesias in reported areas of the patient’s chronic pain in the left leg, thus the 
subject was blinded to stimulation modality. SCS amplitudes were identified during 
sensory threshold testing, and 1.5x sensory threshold was chosen as the experimental 
amplitude for each parameter set due to the potential for discomfort with higher 
stimulation amplitudes during prolonged testing. 
2.5 WALKING TASK AND MODULE CLASSIFICATION 
Following proprioceptive testing, the subject performed a 
walking task at the 800 sq. foot Locomotor Energetics & 
Assessment Laboratory at the Medical University of South Carolina 
(MUSC). A thoracic harness (model # M120, Robertson 
Mountaineering, Fort Collins, CO) anchored to the ceiling over the 
floor-mounted treadmill (FIT, Instrumental Treadmill, Bertec, 
Scotland, U.K) was used to safeguard against a potential fall (weight 
limit = 300 lbs). Vertical ground reaction forces were recorded from 
Figure17: Subject fitted 
with LED markers during 
walking task. 
i  17: ubject fitt  
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the treadmill in order to determine gait cycles, where heel strike and toe off were 
thresholded at 20 newtons or greater. Kinematic tracking was performed using LED 
markers placed over 64 anatomical regions of interest (Fig.17), allowing a 16-camera 
motion capture system (Impulse, PhaseSpace, San Leandro, CA) mounted throughout 
the room facing the treadmill to collect time-stamped positional data throughout the task. 
Marker coordinates were recorded at 120 Hz. The orientation of each tracked segment 
was obtained through a least-squares approach by matching the marker locations in the 
segment's reference frame to the marker coordinates in the global reference frame. The 
pose of segments with less than 3 visible markers could not be calculated. Surface EMG 
(model DE 2.1, DELSYS Incorporated, Natick, MA) using 99% silver electrodes was 
recorded bilaterally from the gluteus medius, semimembranosus, biceps femoris, vastus 
medialis, rectus femoris, tibialis anterior, soleus and medial gastrocnemius. EMG was 
sampled at 2,000 Hz using a 32-channel recording device (MA300 system, Motion Labs, 
Baton Rouge, LA) and high pass filtered at 40 Hz. Observed EMG signals recorded 
during walking exhibited higher degrees of noise from dynamic movement, therefore a 
larger high pass filter than that used for EMG data collected during SCS testing at rest 
was used. 
The subject was asked to walk at a normal pace for one minute per tested 
condition, with the initial 10 seconds being used to optimize steady-state walking 
conditions and the remaining time to be used for capture of at least 10 consecutive 
steady state gait cycles. Trials included baseline recording during gait with no SCS 
stimulation, 600 Hz HFBS with a 40 Hz inter-burst and 140 s pulse width, and 40 Hz 
LFTS with a 140 s pulse width. Both SCS parameters tested were applied at their 
respective 1.5x sensory threshold amplitudes found prior to proprioception testing.  
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Segments of EMG recorded during walking at self-selected walking speed were 
used to investigate complexity of muscle synergies using a nonnegative matrix 
factorization (NNMF) algorithm (MATLAB®, Mathworks, Natick, MA). The approach 
illustrated in figure 18 involves calculation of an mxt matrix of the original EMG data 
(EMG0), where m represents the number of muscles being measured and t represents a 
time base normalized to percentage of gait cycle. The algorithm also calculates two 
surrogate matrices, mxn and nxt, where n is the amplitude of muscle activation.31 The 
product of the surrogate matrices are considered a reconstruction of EMG (EMGr). EMGr 
for each module is then compared to EMG0 by finding the variability accounted for (VAF) 
(Equation 1). 
(𝑉𝐴𝐹 = 1 − [𝐸𝑀𝐺𝑜 − 𝐸𝑀𝐺𝑟]2/𝐸𝑀𝐺𝑜2) 
VAF was applied for all 8 eight muscles and across 6 phases of the gait cycle (1 - 
first double support, 2 - first half of ipsilateral single leg stance, 3 - second half of 
Figure 18: Figure taken from Clark et al [29]. Illustration of the NNMF process over three gait cycles where A) is the 
original EMG, B) shows the iterative NNMF process where muscle activation timing profiles and muscle activation 
amplitudes are reconstructed to closely resemble the original EMG and C) the summation of motor modules represent the 
final reconstructed EMG signal. 
Figure 18: Figure taken fro  lark et al [29]. Illustration of the F process over three gait cycles here ) is the 
original , ) sho s the iterative F process here uscle activation ti ing profiles and uscle activation 
a plitudes are reconstructed to closely rese ble the original  and ) the su ation of otor odules represent the 
final reconstructed  signal. 
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ipsilateral single leg stance, 4 - second double support, 5 - first half of ipsilateral swing, 6 
- second half of ipsilateral swing), where a threshold necessary for module classification 
was chosen to be 90% for all 14 conditions (8 muscles + 6 phases of gait) based on 
similar studies in the literature.31,38  Classifications were not increased unless the higher 
module VAF was at least 5% higher than the preceding module. In Clarke’s study, the 
lowest EMG moduling complexity was 2 and represents a gait pattern characterized by 
high tone throughout the lower extremities and dominated by the stance and swing 
phases. The gait pattern of these individuals is severely impaired. An EMG moduling 
complexity of 4 represents normal gait pattern and muscle activations. 
2.6 STATISTICAL ANALYSIS 
All statistical tests were performed using (MATLAB®, Mathworks, Natick, MA). 
Data were tested for normality using an Anderson-Darling normality test. For aim 2, a 
non-parametric Kruskal-Wallis test was used to compare EMG amplitude and interpulse 
interval (IPI) during extraoperative SCS testing to determine sensory threshold. We 
compared three groups: 40 Hz LFTS, 600 Hz HFBS and 1200 Hz HFBS. Also for aim 2, 
TTDPM values were analyzed using a one-way ANOVA to compare data recorded 
during no stimulation, HFBS and LFTS. In aim 3, step height data collected during the 
walking task were analyzed using a one-way ANOVA to compare effects from no 
stimulation, HFBS and LFTS. All error bars and shading represent standard error.  
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3.0  RESULTS 
Our study involved a 74-year-old male subject with chronic neuropathic pain of 
the lower back and bilateral legs (left worse than right). The subject was previously 
diagnosed with lumbar radiculopathy and had undergone multiple thoracic spine 
surgeries. Pain severity was rated at 8 / 10 on a Numeric Rating Scale (NRS) ranging 
from 0-10 with 0 being no pain and 10 being severe disabling pain. The patient had 
failed conservative measures, including physical therapy. He was referred to Dr. 
Rowland for evaluation for spinal cord stimulator. He underwent a full 
neuropsychological evaluation which judged him to be cognitively competent for the 
procedure. The patient was informed of and consented to the research protocol. SCS 
placement was performed using a 32-electrode paddle array (CoverEdge™, Boston 
Scientific, Marlborough, MA) implanted at the T7-9 vertebral levels, confirmed via 
intraoperative fluoroscopy. 
3.1 EMG RESPONSE DURING INTRAOPERATIVE SCS 
SSEP collision testing during SCS was performed in order to ascertain the SCS 
amplitude needed during 40 Hz LFTS to recruit underlying A fibers. SCS stimulation 
began at 1.0 mA and increased in increments of 1.0 mA until attenuation of both P37 
and N45 waveforms was witnessed via live recordings of cortical deflections using the 
IOMAX stimulation and recording system. A stimulation amplitude of 4.0 mA was found 
to be necessary for SSEP attenuation, shown in figure 19, in which the baseline cortical 





Using the SCS amplitude of 4.0 mA from SSEP collision testing, multiple SCS parameter 
types were then tested while recording EMG from lower extremity muscles. Three 
stimulation parameters were chosen: LFTS - 40 Hz, 300 s, 4.0 mA, HFBS - 600 Hz 
intraburst, 40 Hz interburst, 300 s, 4.0 mA and HFBS - 1200 Hz intraburst, 40 Hz 
interburst, 140 s, 4.0 mA. LFTS at 40 Hz was chosen due to its high prevalence of use 
for both pain mitigation and motor rehabilitation studies. HFBS at 600 Hz was selected 
based on the hypothesis by Formento and colleagues that 600 Hz HFBS would optimally 
preserve proprioceptive information based on primary afferent modeling.3 HFBS at 1200 
Hz was also selected for testing due to the SCS system having a max frequency 






HFBS using a 
frequency of 600 
Hz intraburst, 40 
Hz interburst, 300 
s pulse width 
Figure 19: Cortical activity showing P37 and N45 waveforms during SSEP baseline testing (white) and during SSEP 
collision testing using 40 Hz LFTS at an amplitude of 4.0 mA (purple) 
i r  : rti l ti it  i     f r  ri   li  t ti  ( it )  ri   
lli i  t ti  using 40 Hz LFTS at an amplitude of 4.0 mA (purple). Waveforms represent average response to 
SSEP stimuli (n = 200). 
Figure 20: EMG response in Right Tibialis Anterior to varying SCS parameters at 4.0 
mA. The onset of stimulation is represented with a red vertical line. 
Figure 20: EMG response in Right Tibialis Anterior to varying SCS parameters at 4.0 mA. 
The onset of stimulation is represented with a red vertical line. 
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and amplitude of 4.0 mA. Figure 20 shows filtered EMG responses from the right TA to 
40 Hz LFTS, 600 Hz HFBS and 1200 Hz HFBS. Voltage amplitudes of EMG response 
are represented along the Y-axis while time is along the X-axis, where the red vertical 
line indicates the start of SCS for each parameter set. Although EMG responses to right 
tibialis anterior are shown, robust changes in EMG activity were observed in all recorded 
musculature on the ipsilateral side of stimulation using the 600 Hz HFBS only.  
3.2 EMG RESPONSE TO SCS DURING SENSORY TESTING 
Following thirty days of recovery, the subject returned for further SCS testing in 
which subjective feedback could be documented. Sensory threshold testing (i.e., 
increasing SCS intensity until the subject perceives the stimulation) was performed with 
similar SCS parameters used during intraoperative testing and are shown in Table 1 
below. 
 
Table 1: SCS parameters used for later EMG testing and corresponding amplitude necessary for subject to perceive 
stimulation 
Stimulation Type / Pulse width Perceived Sensory Threshold Amplitude (mA) 
40 Hz, LFTS / 140 s  9.6 
600 Hz, HFBS, 40 Hz interburst / 140 s 3.7 
1200 Hz, HFBS, 40 Hz interburst / 140 s 2.8 
 
 
Although the stimulation types used during intraoperative investigation remained 
constant, both 40 Hz LFTS and 600 Hz HFBS had pulse width standardized to 140 s to 
more accurately compare effects among the different parameters. The subject reported 
equal amounts of pain reduction among all three parameter types at the 1.5x perceived 
sensory threshold level.  Using information obtained during extraoperative perceived 
sensory threshold testing, we measured EMG responses to each parameter tested. SCS 
 
 31 
amplitudes were increased from sensory threshold, to 1.5x sensory threshold and up to 
2.0x sensory threshold (beyond which the subject reported discomfort). EMG analysis 
was performed on signals recorded at the 2.0x sensory threshold amplitude. 
Figure 21 shows filtered EMG activity from the left soleus during individual 
parameter testing of 40 Hz LFTS, 600 Hz HFBS and 1200 Hz HFBS, where EMG 
voltage is represented along the Y-axis and time along the X-axis. Superimposed over 
the raw EMG is a green vertical line showing the start of 1.5x sensory threshold SCS, a 




threshold and a 
blue box outlining 








response to 600 
Hz HFBS when compared to 40 Hz LFTS and 1200 Hz HFBS (p < 0.001, Kruskal-Wallis 
test). Evoked potentials were not observed in the EMG data of either vastus lateralis or 
tibialis anterior muscles during 1200 Hz HFBS, therefore no statistical analysis were 
performed comparing those groups. In Table 2, the mean amplitude of evoked potentials 
Figure 19: Analysis of evoked potentials where Top) shows filtered EMG response to SCS, 
Middle) a scatter plot of amplitude data for selected evoked potentials and, Bottom) mean 
amplitude of selected potentials with standard error. * ( p < .001, Kruskal-Wallace ) 
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for all muscles recorded along with mean interpeak interval calculated during HFBS and 




Table 2:   Data collected during SCS testing at 2.0x sensory threshold with evoked potential amplitude, IPI and 
corresponding p-values shown. 










40 Hz, LFTS 19.2 33.7 ± 0.7  
< .01 
302.6 ± 11.3  
< .01 
VL 600 Hz, HFBS, 40 
Hz interburst 





40 Hz, LFTS 19.2 39.2 ± 0.8  
< .01 
296.1 ± 71.1  
< .01 
TA 600 Hz, HFBS, 40 
Hz interburst 
7.4 69.7 ± 0.9 54.5 ± 0.3 
Group 3 
 
Soleus (SOL) 40 Hz, LFTS 19.2 90.4 ± 1.2  
 
< .01 
33.5 ± 0.4  
 
< .01 SOL 600 Hz, HFBS, 40 
Hz interburst 
7.4 143.0 ± 2.6 25.4 ± 0.2 
SOL 1200 Hz, HFBS, 40 
Hz interburst 













3.3 DIFFERENCES IN PASSIVE MOTION DETECTION 
Due to prolonged SCS activation at 2.0x sensory threshold, the TTDPM test was 
completed using stimulation amplitudes at 1.5x sensory threshold for the 40Hz LFTS 
and 600 Hz HFBS 
parameters. Figure 
22 shows results of 
the TTDPM among 
the three testing 
conditions being 1) 
no stimulation, 2) 
600 Hz intraburst, 40 
Hz interburst, 140 
s, 7.4 mA and, 3) 
40 Hz, 140 s, 14.4 
mA. Results from a 
one-way ANOVA test 
for the 10 trials per 
tested condition 
indicate a non-significant difference between no stimulation and the HFBS parameter 
set, with a significant difference existing between LFTS and the other two testing 
conditions (p < .001).  
3.4 DIFFERENCES IN MODULE CLASSIFICATION AND KINEMATICS 
Muscle activation patterns and kinematic features observed during gait can be 
quantified by a measure known as EMG moduling complexity. We compared EMG 
Figure 22: Results from the TTDPM showing, Top) illustration of the TTDPM testing 
process, Middle) a scatter plot of recorded degrees of passive flexion/extension before 
detection and Bottom) mean degrees of knee flexion/extension passively applied before 
subject recognizes movement. 
Figure 20: Results from the TTDPM showing, Top) illustration of the TTDPM testing 
process, Middle) a scatter plot of recorded degrees of passive flexion/extension before
detection and Bottom) mean degre s of knee flexion/extension passively applied
subject recognizes oveme t. * ( p < .001, One-way Anova) 
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moduling complexity in our subject in response to no stimulation, 40 Hz LFTS and 600 
Hz HFBS (performed at 1.5x sensory threshold for each stimulation parameter).  
Figure 23 displays the muscle weightings among the 4 classified modules, 
corresponding to the 4 components of the gait cycle identified by Clark: early stance, late 
stance, early swing and late swing. EMG was normalized to the highest activated muscle 
(value of 1.0). Normalized EMG amplitudes per module are located along the Y-axis, 
while individual muscles (i.e., channels) are located along the X-axis. The classification 
of EMG modules (See 1.6, 2.4) was found to have no change among the tested 
conditions of 1) no stimulation, 2) 600 Hz intraburst, 40 Hz interburst, 140 s, 7.4 mA 
Figure 23: Results from EMG module classification showing muscle activation patterns among various testing 
conditions where it may be seen that muscle co-activations during functional task are similar 
i  1: lt  f   l  l ifi ti  i  l  ti ti  tt   i  t ti  
iti   it    t t l  ti ti  i  f ti l t   i il
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and, 3) 40 Hz, 140 s, 14.4 mA. All parameters tested resulted in a module complexity 
classification of 4 modules, which represents the highest moduling complexity. 
 Although EMG activity during walking did not deviate among the tested 
conditions in large enough amounts for the NNMF algorithm to differentially assign 
module classification, further investigation of the raw EMG during walking showed 
observable 
differences in 
muscle firing among 
the different SCS 
trials and baseline 
testing. Figure 24 
shows EMG 
amplitude (Y-axis) 
of left TA averaged 
across all completed 
gait cycles 
(normalized by 
percentage of the 
cycle) for each stimulation parameter tested, where TA activity during HFBS (blue) more 
closely resembles TA activity during no stimulation (green) than TA activity during LFTS 
(red) throughout most of the cycle. Specifically, between 50 and 60 % of the gait cycle, 
the pre-swing phase is where TA activity should be minimal allowing proper 
plantarflexion and propulsion. 39 Figure 24 shows results in line with this estimation. 
Baseline gait EMG signal amplitude falls dramatically during this interval, as does the 
amplitude during HFBS but not LFTS. 
Figure 22: EMG recorded from the left tibialis anterior through each testing condition. 
EMG signal is average of all gait cycles during each tested condition. 
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Regarding gait kinematics, significant difference was observed in step height for 
both the left and right foot, with HFBS more closely resembling baseline height for the 
left and right side. Figure 25 shows the gait cycle beginning with right heel strike at 0% 
and ending with the next recurring right heel strike at 100%, where a red box has been 
placed around the mid-swing phase at approximately 80% of the gait cycle where foot 
height should reach a maximum. 
 
  Figure 26 shows several traces of foot height in meters (Y-axis) over 100% of the 
gait cycle (X-axis) 
during no stimulation 
(baseline), HFBS 
and LFTS averaged 
over all completed 
gait cycles with 
shaded regions 
representing 
standard error. A 
non-significant 
difference, using a 
one-way ANOVA, 
Figure 25: image a caption modified from [38]. Illustration of appropriate kinematics during the gait cycle 3 40
Figure 26: Height measurement during gait in meters of the Top) left foot with standard 
error and, Bottom) right foot with standard error. 
4
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exists between baseline testing conditions and trials during HFBS (p > 0.05), and a 
significant difference exists between baseline conditions and trials during LFTS with a p-


























Results from SCS parameter testing during intraoperative stimulator placement 
under general anesthesia, awake sensory threshold testing at rest during EMG recording 
and dynamic walking task during EMG and motion capture suggest that HFBS and LFTS 
differ in several important aspects. Specifically, 600 Hz HFBS may have the unique 
capacity to influence motor pathways of the spinal cord without significantly disrupting 
sensory afferent signaling or significantly impacting movement dynamics during a 
functional task. This could be an important advance in the motor rehabilitation field if this 
result can be replicated in more patients with chronic pain and motor deficits, because it 
points to a possible mechanism of selective sparing of proprioceptive input when 
engaging motor tasks. 
Observations made during intraoperative testing show that LFTS at amplitudes 
necessary to recruit A fibers, seen during the SSEP collision protocol, are not sufficient 
enough to recruit lower motoneurons (MN) of the ventral horn of the spinal cord (VHSC). 
This was also true at the maximum device stimulation frequency of 1200 Hz, regardless 
of burst or nonburst stimulation pattern. In contrast, 600 Hz HFBS produced robust and 
sustained activity in the EMG from all three lower extremity muscles indicating the ability 
to influence downstream targets of the VHCS across multiple spinal levels. The ability of 
600 Hz HFBS to accomplish this task, and the inability of 40 Hz LFTS, may be due to the 
ability of neurons to interpret multiple small amplitude stimuli in high frequency as one 
large stimulus given in a single pulse. While the principle of temporal summation may be 
able to account for the difference in HFBS and LFTS, it would not necessarily explain 
why 600 Hz HFBS and 1200 Hz HFBS do not produce similar results.  
One possible explanation for the difference between 600 Hz and 1200 Hz HFBS 
to recruit VHSC motoneurons might be a phenomenon known as synaptic fatigue, where 
rapid stimuli producing fast trains of action potentials lead to a decay in post synaptic 
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activity, which in this case might implicate the role of interneurons located within the 
superficial dorsal horn of the spinal cord (DHSC). Synaptic fatigue is generally thought to 
occur due to an inability to endocytose vesicles containing neurotransmitters in a rapid 
enough fashion to entrain excitation to neighboring post synaptic densities. However, it 
should also be noted that limitations in stimulator technology did not allow for 1200 Hz 
HFBS to be delivered with a 300 s pulse width, which was used during 600 Hz HFBS, 
and instead was restricted to a 140 s pulse width which may have impacted the ability 
to recruit underlying A fibers. 
The ability of 600 Hz HFBS to recruit A fibers at smaller amplitudes than LFTS 
may explain the ability of HFBS to allow the subject to sense a passive change in knee 
angle in a manner more closely resembling baseline capacity than LFTS. A previous 
study observed that axonal recruitment via SCS is primarily dependent upon stimulation 
amplitude and pulse width, with increases in either parameter leading to production of 
larger electric fields influencing more underlying neuronal structures.3 It is possible that 
the unique combination of 600 Hz intraburst patterning with a 40 Hz interbust interval 
represents a stimulus within the functional and/or optimal ranges of both sensory 
pathways (i.e., pain and proprioception) to allow inhibition of the former and preservation 
of the latter. 
Although a significant difference in EMG module complexity was not observed 
between stimulus modalities, the findings from proprioceptive testing during TTDPM may 
shed light on observed differences in raw EMG activity of certain muscles during the 
walking task. TA activity was seen to be active at inappropriate times during LFTS, 
which was not observed during HFBS. Specifically, TA activity during the late stance 
phase of the gait cycle was elevated compared to HFBS and no stimulation trials and 
may contribute to a lack of propulsion during gait. We speculate that the interference in 
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proprioceptive signaling observed during TTDPM may have led to TA activity being 
improperly regulated by sensory afferents normally responsible for inhibition of 
antagonistic flexor activity during extension. Similar dysregulation, although not 
observed, may also be responsible for the lack of foot height through gait seen during 
LFTS and may account for the similarity between baseline trials with no stimulation and 
trials during HFBS. These findings highlight increased interest in neuromodulation of 
sensorimotor pathways using lower thoracic SCS, where a current clinical trial 
(NCT03586882) is investigating the effect of SCS on gait and balance in subjects with 
chronic pain. 
Possible limitations of the presented study also warrant discussion. The potential 
of SCS to influence sensorimotor pathways of the spinal cord after stimulation has 
ended is not well understood and not explored in this study. For instance, various forms 
of neuromodulation of the cerebrum lead to carryover effects lasting longer than the 
duration of modulation. It is plausible that neuromodulation of the spinal cord may share 
similar principles and presented data may not represent, exclusively, effects of a single 
parameter type. Furthermore, data collection during intraoperative investigation was 
limited to 20 minutes and limited the ability to explore a larger parameter space of the 
SCS system. Finally, as highlighted previously, our findings represent data from only one 
individual. 
In conclusion, we found in one subject that HFBS simultaneously activates more 
muscle groups and spares more proprioceptive signals than LFTS, which is a classical 
form of stimulation used in past investigations of motor recovery after spinal cord injury. 
It is shown that HFBS has the ability to recruit lower MNs at 1) lower stimulation 
amplitude 2) without disrupting proprioceptive signaling and 3) without influencing 
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